RECRUITING

Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body

Official Title

Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications

Quick Facts

Study Start:2012-02
Study Completion:2027-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02663362

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 89 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male or female
  2. * Age 12 - 89
  3. * Healthy (self assessed)
  4. * Weight under 350lbs
  5. * Able to walk 50 yards without stopping
  6. * Able to travel to hospital for study visits
  7. * Able to follow a 3-step command
  8. * Able to remain in Magnetic Resonance (MR) scanner for up to 2 hours
  1. * Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your eye, or non-removable jewelry such as rings.
  2. * Are unwilling or unable to complete the imaging procedures for the duration of the MRI scan due to claustrophobia or other reason.
  3. * Serious mental illness that might preclude subject's ability to comply with study treatment
  4. * Life expectancy of less than 1 year
  5. * Are pregnant or plan on becoming pregnant in the next 8 weeks.

Contacts and Locations

Study Contact

Recruitment Department
CONTACT
407-303-7100
tri@flhosp.org

Principal Investigator

Heather Cornnell, PhD
PRINCIPAL_INVESTIGATOR
Translational Research Institute for Metabolism and Diabetes

Study Locations (Sites)

Translational Research Institute for Metabolism and Diabetes
Orlando, Florida, 32804
United States

Collaborators and Investigators

Sponsor: AdventHealth Translational Research Institute

  • Heather Cornnell, PhD, PRINCIPAL_INVESTIGATOR, Translational Research Institute for Metabolism and Diabetes

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2012-02
Study Completion Date2027-01

Study Record Updates

Study Start Date2012-02
Study Completion Date2027-01

Terms related to this study

Keywords Provided by Researchers

  • magnetic resonance imaging
  • magnetic resonance spectroscopy

Additional Relevant MeSH Terms

  • Human Body Composition
  • Human Body Function